Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Dag Josefsen"'
Autor:
Sólrún Melkorka Maggadóttir, Gunnar Kvalheim, Patrik Wernhoff, Stein Sæbøe-Larssen, Mona-Elisabeth Revheim, Dag Josefsen, Sébastien Wälchli, Åslaug Helland, Else Marit Inderberg
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundAdoptive cellular therapy (ACT) with genetically modified T cells aims to redirect T cells against resistant cancers through introduction of a T cell receptor (TCR). The Radium-4 TCR was isolated from a responding patient in a cancer vaccin
Externí odkaz:
https://doaj.org/article/60e4d16bba4146cda688a9bb43b7ba8b
Autor:
Gunnar Kvalheim, Frauke Schnorfeil, Christiane Geiger, Iris Bigalke, Dolores Schendel, Dag Josefsen, Yngvar Floisand, Anna Tafuri, Kai Pinkernell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/6c94e68e3cd24965bd724d4a6aaf018d
Autor:
Shadab Abadpour, Essi M. Niemi, Linnea Strid Orrhult, Carolin Hermanns, Rick de Vries, Liebert Parreiras Nogueira, Håvard Jostein Haugen, Dag Josefsen, Stefan Krauss, Aart van Apeldoorn, Paul Gatenholm, Hanne Scholz
Intra-portal islet transplantation is the method of choice for treatment of insulin dependent type 1 diabetes, but its outcome is hindered by limited islet survival due to the immunological and metabolic stress post transplantation. Adipose-derived s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b4e1a680c43a3a13ab4497c1795355c
https://doi.org/10.1101/2022.05.30.494035
https://doi.org/10.1101/2022.05.30.494035
Autor:
Svein Dueland, Karol Axcrona, Ulrika Axcrona, Lisbeth Skoge, Rolf Inge Skotheim, Stein Sæbøe-Larssen, Dolores J. Schendel, Dag Josefsen, Gunnar Kvalheim, Steinar Aamdal, Iris Bigalke, Guri Solum, Anne Merete Aaland Tryggestad, Tor Åge Myklebust, Bjørn Brennhovd, Else Marit Inderberg, Wolfgang Lilleby, Turid Kirsti Hønnåshagen, Richard W Olaussen
Publikováno v:
The ProstateREFERENCES. 82(2)
Background Patients with high-risk prostate cancer (PC) can experience biochemical relapse (BCR), despite surgery, and develop noncurative disease. The present study aimed to reduce the risk of BCR with a personalized dendritic cell (DC) vaccine, giv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fefaad5a15defeb357b420ffffd3c7a2
https://pubmed.ncbi.nlm.nih.gov/34762317
https://pubmed.ncbi.nlm.nih.gov/34762317
Autor:
Dolores J. Schendel, Christiane Geiger, Yngvar Fløisand, Dag Josefsen, Kai Pinkernell, Anna Tafuri, Gunnar Kvalheim, Frauke M. Schnorfeil, Iris Bigalke
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background A Phase I/II dendritic cell (DC) vaccine trial was completed in 20 patients with acute myeloid leukemia (AML) in complete remission or CRi after chemotherapy who were ineligible for hematopoietic stem cell transplantation (NCT02405338). Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac61b782735bc04dd319453d601d1c7
https://doi.org/10.1136/jitc-2020-sitc2020.0271
https://doi.org/10.1136/jitc-2020-sitc2020.0271
Autor:
Anne Merete Aaland Tryggestad, Iris Bigalke, Wolfgang Lilleby, Karol Axcrona, Turid Kirsti Hønnåshagen, Lisbeth Johanne Skoge, Stein Sæbøe-Larssen, Guri Solum, Richard Willfred Olaussen, Dag Josefsen, Dolores Schendel, Gunnar Kvalheim
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87adfef45e87cf826056bf73b36b1f0a
https://doi.org/10.26502/jcsct.5079081
https://doi.org/10.26502/jcsct.5079081
Autor:
Gunnar Kvalheim, Linnea Strid Orrhult, Dag Josefsen, Hanne Scholz, Essi Maria Niemi, Håvard J. Haugen, Paul Gatenholm, L.P. Nogueira, Shadab Abadpour, Stefan Krauss
Publikováno v:
Transplantation. 105:S25-S25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::980859a9b256d68393fc2eee1d461d59
https://doi.org/10.1097/01.tp.0000804424.50335.7e
https://doi.org/10.1097/01.tp.0000804424.50335.7e
Autor:
Mengyu Wang, Olle Korsgren, Gunnar Kvalheim, Dag Josefsen, Aksel Foss, Hans Petter Gullestad, Hanne Scholz, Simen W. Schive, Grete Hasvold, Mohammad Reza Mirlashari
Publikováno v:
Cell Medicine. 9:103-116
Adipose-derived mesenchymal stem cells (ASCs) release factors beneficial for islets in vitro and protect against hyperglycemia in rodent models of diabetes. Oxygen tension has been shown to induce metabolic changes and alter ASCs' release of soluble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec5df3e2b64c1aa1a7dd20987c6d4373
https://doi.org/10.3727/215517917x693401
https://doi.org/10.3727/215517917x693401
Autor:
Yngvar Fløisand, Mats Remberger, Dag Josefsen, Richard Addo, Kai Pinkernell, Gunnar Kvalheim, Dolores J. Schendel, Iris Bigalke
Publikováno v:
Transplantation and Cellular Therapy. 27:S337
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfd329aeba82204190b5fe9c37d78c4d
https://doi.org/10.1016/s2666-6367(21)00433-4
https://doi.org/10.1016/s2666-6367(21)00433-4
Autor:
Frauke M. Schnorfeil, Kai Pinkernell, Yngvar Fløisand, Richard Addo, Dolores J. Schendel, Gunnar Kvalheim, Iris Bigalke, Silke Raffegerst, Dag Josefsen
Publikováno v:
Blood. 136:11-11
Patients with acute myeloid leukemia (AML), not eligible for allogeneic hematopoietic stem cell transplantation (AHSCT), have a significant risk of disease relapse and death due to a lack of long-term disease control. To investigate the possibility o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::615d6afa955e38314a44de6b371c92c2
https://doi.org/10.1182/blood-2020-139255
https://doi.org/10.1182/blood-2020-139255